Osteoprotegerin, C- Reactive protein and Fibroblast Growth Factor-23 in Stage (II-IV) CKD Patients and Their potential for Increased incidence of Cardiovascular Disorders. IJPHRD [Internet]. 2020 Aug. 31 [cited 2025 Jul. 12];11(8):206-13. Available from: https://medicopublication.com/index.php/ijphrd/article/view/10923